The oncoprotein H-RasV12 increases mitochondrial metabolism

Area of Science:

• Oncology
• Cell Metabolism
• Cancer Biology

Background:

• Neoplastic cells rely on glycolysis for energy and precursors in hypoxic tumor environments.
• Ras signaling, active in many cancers, regulates metabolism by increasing glycolytic flux to lactate.
• The study investigates the metabolic fate of glucose carbons in immortalized and H-RasV12-transformed human bronchial epithelial cells.

Purpose of the Study:

• To examine the impact of H-RasV12 transformation on glucose metabolism in bronchial epithelial cells.
• To understand how Ras signaling influences cellular anabolism and mitochondrial activity.
• To identify potential therapeutic targets within cancer cell metabolism.

Main Methods:

• Utilized two-dimensional total correlated spectroscopy-nuclear magnetic resonance spectroscopy (2D TOCSY-NMR) with fully labeled 13C-glucose.
• Analyzed the incorporation of 13C-glucose carbons into anabolic substrates.
• Measured oxygen consumption as an indicator of electron transport chain activity.

Main Results:

• H-RasV12 expression unexpectedly increased tricarboxylic acid cycle activity, evidenced by 13C-glucose conversion to glutamate/glutamine, aspartate, and uridine.
• Both immortalization and H-RasV12 transformation led to a stepwise increase in oxygen consumption, indicating enhanced electron transport chain activity.
• H-RasV12 expression sensitized cells to rotenone-induced ATP depletion and cytotoxicity, highlighting the dependency on electron transport chain function.

Conclusions:

• The oncoprotein H-RasV12 enhances mitochondrial metabolism.
• These findings provide a rationale for targeting the tricarboxylic acid cycle and electron transport chain in cancer therapy.
• Targeting mitochondrial pathways represents a promising anti-neoplastic strategy.